Guo Zhiqiang, Liu Yunfeng, Gao Xiaoling, Li Runjie, Zhao Lichun
Department of Emergency, the First Affiliated Hospital of Hebei North University, Zhangjiakou 075061, Hebei, China.
Department of Hyperbaric Oxygen, the First Affiliated Hospital of Hebei North University, Zhangjiakou 075061, Hebei, China.
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024 Jul;36(7):712-716. doi: 10.3760/cma.j.cn121430-20240324-00263.
To explore the correlation between serum nitric oxide synthase (NOS) levels and readmission due to acute exacerbation within 30 days in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD).
A prospective cohort study was conducted. The AECOPD patients admitted to the First Affiliated Hospital of Hebei North University from January 2020 to December 2022 were enrolled as the research subjects. The general data such as gender, age, body mass index (BMI), chronic obstructive pulmonary disease (COPD) course, smoking history, and basic diseases were collected. The laboratory indicators, serum NOS level [inducible nitric oxide synthase (iNOS), endothelial nitric oxide synthase (eNOS), neuronal nitric oxide synthase (nNOS)] and acute physiology and chronic health evaluation II (APACHE II) score within 24 hours after admission and total length of hospital stay were also collected, and whether patients were readmitted due to acute exacerbation within 30 days after discharge were recorded. The differences in the above clinical indexes between the readmitted and non-readmitted patients within 30 days were compared. Multivariate Logistic regression analysis was used to screen the influencing factors of readmission within 30 days after discharge in AECOPD patients. Receiver operator characteristic curve (ROC curve) was drawn to analyze the predictive value of various influencing factors on readmission.
A total of 168 patients were enrolled, 38 patients were readmitted due to acute aggravation within 30 days after discharge, and 130 were not readmitted. Compared with the non-readmission group, the levels of white blood cell count (WBC), C-reactive protein (CRP), APACHE II score, and serum iNOS and eNOS levels within 24 hours after admission in the readmission group were significantly increased [WBC (×10/L): 14.19 (12.88, 16.12) vs. 11.81 (10.63, 14.11), CRP (mg/L): 51.41±12.35 vs. 40.12±7.79, APACHE II score: 22.0 (19.0, 25.0) vs. 18.0 (14.0,20.5), iNOS (μg/L): 5.87±1.36 vs. 4.52±0.89, eNOS (μg/L): 4.40±1.00 vs. 3.51±1.08, all P < 0.01], and the levels of hemoglobin (Hb) and albumin (Alb) were significantly decreased [Hb (g/L): 108.82±22.06 vs. 123.98±24.26, Alb (g/L): 30.28±3.27 vs. 33.68±2.76, both P < 0.01]. There were no significant differences in gender, age, BMI, COPD course, smoking history, basic diseases, total length of hospital stay and serum nNOS level between the two groups. Multivariate Logistic regression analysis showed that CRP [odds ratio (OR) = 1.201, 95% confidence interval (95%CI) was 1.075-1.341], APACHE II score (OR = 1.335, 95%CI was 1.120-1.590), and serum iNOS (OR = 5.496, 95%CI was 2.143-14.095) and eNOS (OR = 3.366, 95%CI was 1.272-8.090) were the independent risk factors for readmission within 30 days after discharge in AECOPD patients (all P < 0.05), and Hb (OR = 0.965, 95%CI was 0.933-0.997) and Alb (OR = 0.551, 95%CI was 0.380-0.799) were protective factors (both P < 0.05). ROC curve analysis showed that serum iNOS and eNOS levels had predictive value for readmission within 30 days after discharge in AECOPD patients, and the area under the ROC curve (AUC) was 0.791 (95%CI was 0.694-0.887) and 0.742 (95%CI was 0.660-0.823), respectively. When the optimal cut-off value was 5.22 μg/L and 3.82 μg/L, the sensitivity was 81.54% and 69.23%, and the specificity was 71.05% and 81.58%, respectively. The AUC of serum iNOS and eNOS levels combined with Hb, Alb, CRP and APACHE II score for predicting the readmission was 0.979 (95%CI was 0.958-1.000), the sensitivity was 91.54%, and the specificity was 97.37%.
The increased serum iNOS and eNOS levels of AECOPD patients correlate with the readmission due to acute exacerbation within 30 days after discharge. Combined detection of Hb, Alb, CRP, serum iNOS and eNOS levels, and evaluation of APACHE II score within 24 hours after admission can effectively predict readmission.
探讨慢性阻塞性肺疾病急性加重期(AECOPD)患者血清一氧化氮合酶(NOS)水平与出院后30天内因急性加重再次入院的相关性。
进行一项前瞻性队列研究。选取2020年1月至2022年12月在河北北方学院附属第一医院住院的AECOPD患者作为研究对象。收集患者的性别、年龄、体重指数(BMI)、慢性阻塞性肺疾病(COPD)病程、吸烟史及基础疾病等一般资料。同时收集患者入院后24小时内的实验室指标、血清NOS水平[诱导型一氧化氮合酶(iNOS)、内皮型一氧化氮合酶(eNOS)、神经型一氧化氮合酶(nNOS)]、急性生理与慢性健康状况评分系统II(APACHE II)评分及住院总时长,并记录患者出院后30天内是否因急性加重再次入院。比较30天内再次入院和未再次入院患者上述临床指标的差异。采用多因素Logistic回归分析筛选AECOPD患者出院后30天内再次入院的影响因素。绘制受试者工作特征曲线(ROC曲线)分析各影响因素对再次入院的预测价值。
共纳入168例患者,其中38例患者出院后30天内因急性加重再次入院,130例未再次入院。与未再次入院组相比,再次入院组患者入院后24小时内白细胞计数(WBC)、C反应蛋白(CRP)、APACHE II评分及血清iNOS和eNOS水平显著升高[WBC(×10/L):14.19((12.88, \ 16.12))比11.81((10.63, \ 14.11)),CRP(mg/L):51.41±1₂.35比40.12±7.79,APACHE II评分:22.0((19.0, \ 25.0))比18.0((14.0, \ 20.5)),iNOS(μg/L):5.87±1.36比4.52±0.89,eNOS(μg/L):4.40±1.00比3.51±1.08,均P < 0.01],血红蛋白(Hb)和白蛋白(Alb)水平显著降低[Hb(g/L):108.82±22.06比123.98±24.26,Alb(g/L):30.28±3.27比33.68±2.76,均P < 0.01]。两组患者在性别、年龄、BMI、COPD病程、吸烟史、基础疾病、住院总时长及血清nNOS水平方面差异无统计学意义。多因素Logistic回归分析显示,CRP[比值比(OR) = 1.201,95%置信区间(95%CI)为1.075 - 1.341]、APACHE II评分(OR = 1.335,95%CI为1.120 - 1.590)、血清iNOS(OR = 5.496,95%CI为2.143 - 14.095)和eNOS(OR = 3.366,95%CI为1.272 - 8.090)是AECOPD患者出院后30天内再次入院的独立危险因素(均P < 0.05),而Hb(OR = 0.965,95%CI为0.933 - 0.997)和Alb(OR = 0.551,95%CI为0.380 - 0.799)是保护因素(均P < 0.05)。ROC曲线分析显示,血清iNOS和eNOS水平对AECOPD患者出院后30天内再次入院有预测价值,ROC曲线下面积(AUC)分别为0.791(95%CI为0.694 - 0.887)和0.742(95%CI为0.660 - 0.823)。当最佳截断值分别为5.22 μg/L和3.82 μg/L时,灵敏度分别为81.54%和69.23%,特异度分别为71.05%和81.58%。血清iNOS和eNOS水平联合Hb、Alb、CRP及APACHE II评分预测再次入院的AUC为0.979(95%CI为0.958 - 1.000),灵敏度为91.54%,特异度为97.37%。
AECOPD患者血清iNOS和eNOS水平升高与出院后30天内因急性加重再次入院相关。入院后24小时内联合检测Hb、Alb、CRP、血清iNOS和eNOS水平,并评估APACHE II评分可有效预测再次入院情况。